Association of increased urine brain derived neurotrophic factor with lower urinary tract symptoms in men with benign prostatic hyperplasia

Abstract

Urinary brain-derived neurotrophic factor (BDNF), an ubiquitous neurotrophin, was found to rise in patients with benign prostatic hyperplasia (BPH). We hypothesized that the urinary level of BDNF could be a potential biomarker for lower urinary tract symptoms (LUTS) in patients with BPH. Totally, 76 patients with BPH-caused LUTS and 32 male control subjects without BPH were enrolled. International Prostate Symptom Score (IPSS) was applied to assess the symptom severity of LUTS. Urodynamic tests were performed for the diagnosis of underlying detrusor overactivity (DO) in the patients with BPH. Urine samples were collected from all subjects. Urinary BDNF levels were measured using enzyme-linked immunosorbent assays and normalized by urinary creatinine (Cr) levels. Seventy-six BPH patients were divided into moderate LUTS group (n=51, 7<IPSS≤20) and severe LUTS group (n=25, IPSS>20) according to the IPSS. Of the 76 BPH patients, DO was present in 34 (44.7%) according to the urodynamic test. The urinary BDNF/Cr levels were significantly higher in BPH patients with moderate LUTS (8.29±3.635, P<0.0001) and severe LUTS (11.8±6.44, P<0.0001) than normal controls (1.71±0.555). Patients with severe LUTS tended to have higher urinary BDNF/Cr levels than patients with moderate LUTS (11.8±6.44 vs. 8.29±3.635, P=0.000). The conditions of BPH with LUTS correlated with elevated urinary BDNF levels, and urinary BDNF levels were even higher in BPH-DO patients. The results of this study have provided evidence to suggest that urinary BDNF level test could evaluate the severity of LUTS in BPH patients, and BDNF level can be used as a biomarker for the diagnosis of DO in BPH patients.

Keywords

biomarker / increased urine brain derived neurotrophic factor / lower urinary tract symptoms / benign prostatic hyperplasia

References

[1] PetersTJ, DonovanJL, KayHE, et al. . The International Continence Society “Benign Prostatic Hyperplasia” Study: the botherosomeness of urinary symptoms. J Urol, 1997, 157(3): 885-889 PMID: 9072592

[2] ChuteCG, PanserLA, GirmanCJ, et al. . The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol, 1993, 150(1): 85-9 PMID: 7685427

[3] LiuHT, ChancellorMB, KuoHC. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol, 2009, 56(4): 700-706 PMID: 18472208

[4] LiuHT, KuoHC. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment. Urology, 2008, 72(1): 104-8 PMID: 18400272

[5] LiuHT, KuoHC. Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder. J Urol, 2008, 179(6): 2270-2274 PMID: 18423678

[6] WangLW, HanXM, ChenCH, et al. . Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder. Int Urol Nephrol, 2014, 46(2): 341-347 PMID: 23982767

[7] PezetS, McMahonSB. Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci, 2006, 29: 507-538 PMID: 16776595

[8] WozniakW. Brain-derived neurotrophic factor (BDNF): role in neuronal development and survival. Folia Morphol (Warsz), 1993, 52(4): 173-181

[9] FarinasI. Neurotrophin actions during the development of the peripheral nervous system. Microsc Res Tech, 1999, 45(4-5): 233-242

[10] HellardD, BrosenitschT, FritzschB, et al. . Cranial sensory neuron development in the absence of brain-derived neurotrophic factor in BDNF/Bax double null mice. Dev Biol, 2004, 275(1): 34-43 PMID: 15464571

[11] MerighiA, BardoniR, SalioC, et al. . Presynaptic functional trkB receptors mediate the release of excitatory neurotransmitters from primary afferent terminals in lamina II (substantia gelatinosa) of postnatal rat spinal cord. Dev Neurobiol, 2008, 68(4): 457-475 PMID: 18172890

[12] KerrBJ, BradburyEJ, BennettDL, et al. . Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord. J Neurosci, 1999, 19(12): 5138-5148 PMID: 10366647

[13] QiaoLY, VizzardMA. Cystitis-induced upregulation of tyrosine kinase (TrkA, TrkB) receptor expression and phosphorylation in rat micturition pathways. J Comp Neurol, 2002, 454(2): 200-211 PMID: 12412144

[14] QiaoLY, VizzardMA. Spinal cord injury-induced expression of TrkA, TrkB, phosphorylated CREB, and c-Jun in rat lumbosacral dorsal root ganglia. J Comp Neurol, 2005, 482(2): 142-154 PMID: 15611995

[15] PintoR, LopesT, FriasB, et al. . Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/ interstitial cystitis. Eur Urol, 2010, 58(3): 360-365 PMID: 20227820

[16] Antunes-LopesT, Carvalho-BarrosS, CruzCD, et al. . Biomarkers in overactive bladder: a new objective and noninvasive tool?. Adv Urol, 2011, 2011: 1-7

[17] ObataK, NoguchiK. BDNF in sensory neurons and chronic pain. Neurosci Res, 2006, 55(1): 1-10 PMID: 16516994

[18] ZhangEY, SteinR, ChangS, et al. . Smooth muscle hypertrophy following partial bladder outlet obstruction is associated with overexpression of non-muscle caldesmon. Am J Pathol, 2004, 164(2): 601-612 PMID: 14742265 PMCID: 1602268

[19] ZvaraP, KlimentJ, DeRossAL, et al. . Differential expression of bladder neurotrophic factor mRNA in male and female rats after bladder outflow obstruction. J Urol, 2002, 168(6): 2682-2688 PMID: 12442010

[20] YoshimuraN. Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder. Prog Neurobiol, 1999, 57(6): 583-606 PMID: 10221783

[21] LiuZ, MaD, FengG, et al. . Recombinant AAV-mediated expression of human BDNF protects neurons against cell apoptosis in Abeta-induced neuronal damage model. J Huazhong Univ Sci Technolog Med Sci, 2007, 27(3): 233-236 PMID: 17641830

[22] PintoR, FriasB, AllenS, et al. . Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis. Neuroscience, 2010, 166(3): 907-916 PMID: 20079809

[23] Cruz DuarteP, St-JacquesB, MaW. Prostaglandin E2 contributes to the synthesis of brain-derived neurotrophic factor in primary sensory neuron in ganglion explant cultures and in a neuropathic pain model. Exp Neurol, 2012, 234(2): 466-481 PMID: 22309829

[24] AnderssonKE. Storage and voiding symptoms: pathophysiologic aspects. Urology, 2003, 62: 3-10 PMID: 14662401

[25] OelkeM, BaardJ, WijkstraH, et al. . Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Eur Urol, 2008, 54(2): 419-426 PMID: 18325657

[26] BlaivasJG, MarksBK, WeissJP, et al. . Differential diagnosis of overactive bladder in men. J Urol, 2009, 182(6): 2814-2817 PMID: 19837417

[27] KlinglerHC, MadersbacherS, DjavanB, et al. . Morbidity of the evaluation of the lower urinary tract with transurethral multichannel pressure-flow studies. J Urol, 1998, 159(1): 191-194 PMID: 9400470

[28] WadieB E e H, GomhaMA. The relationship of detrusor instability and symptoms with objective parameters used for diagnosing bladder outlet obstruction: a prospective study. J Urol, 2002, 168(1): 132-134 PMID: 12050506

[29] HymanMJ, GroutzA, BlaivasJG. Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings. J Urol, 2001, 166(2): 550-552 PMID: 11458066

[30] LiuHT, KuoHC. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention. Neurourol Urodyn, 2009, 28(1): 78-81 PMID: 19089891